DIAGNOS Welcomes Founder of National Vision Associates, Ed Weiner, to its Advisory Board for the United States

On June 10, 2025, Diagnos Inc. (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a leader in utilizing Artificial Intelligence (AI) for early detection of critical health issues, announced the addition of Ed Weiner to its Advisory Board for the United States. Mr. Weiner, a highly experienced entrepreneur in the optical sector, will collaborate with Dr. Tomas J. Philipson, a former vice chairman of the White House Council of Economic Advisers, to enhance DIAGNOS's understanding of the US optical landscape.

Weiner's impressive track record includes founding National Vision Associates, one of America’s largest optical retail chains, as well as introducing the Ralph Lauren Eyewear line and partnering with Walmart to establish 400 optical locations. His insights are expected to significantly influence DIAGNOS's strategy as it aims to expand its AI-driven healthcare solutions in the U.S. market.

André Larente, President and CEO of DIAGNOS, expressed enthusiasm about Weiner's appointment, emphasizing that his extensive knowledge of the optical market will be instrumental in positioning DIAGNOS at the forefront of AI applications among opticians and optometrists across the country. Given that approximately 111 million routine eye exams and 60 million medical eye exams took place in the U.S. in 2020, DIAGNOS sees a substantial opportunity to address this growing market.

In line with its expansion efforts, DIAGNOS has opened a new office in south Florida to better serve U.S. prospects and clients. The company remains committed to leveraging AI to enhance diagnostic accuracy and improve patient outcomes globally. Additional information about DIAGNOS can be found on their website and SEDAR+, with a cautionary note regarding forward-looking statements included in their release.

DIAGNOS Inc. (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A) has made a strategic move by welcoming Ed Weiner, a prominent figure in the optical industry, to its Advisory Board. This appointment, alongside Dr. Tomas J. Philipson’s expertise, positions DIAGNOS to leverage a wealth of knowledge as it aims to penetrate the lucrative U.S. optical market.

Weiner’s extensive experience, including founding National Vision Associates and pioneering partnerships with retailers like Walmart, underscores his capability to navigate complex market dynamics. His insights will be instrumental as DIAGNOS seeks to promote its AI-driven healthcare solutions to opticians and optometrists in the U.S. market, which reportedly conducts over 171 million eye exams annually as per VisionWatch data.

Given DIAGNOS's focus on advanced AI technology for early detection of eye-related health issues, the incorporation of Weiner into the advisory fold can enhance the company’s market strategy and execution. This can potentially improve DIAGNOS's growth trajectory, particularly as demand surges for innovative health solutions amidst an aging population and increased health awareness.

Investors should view this development positively, as it may signal increased market traction and greater revenues in the coming quarters. The establishment of a U.S. office in South Florida is a tactical decision that aligns with this ambitious expansion. It reflects DIAGNOS’s commitment to capitalizing on the growing demand for healthcare technology.

However, potential investors should remain cautious and perform due diligence. The healthcare and technology sectors are subject to regulatory scrutiny, competition, and market volatility. Monitoring DIAGNOS’s strategic developments, partnerships, and financial health will be essential to assess whether the ongoing investments and expansions translate into sustainable growth. In conclusion, DIAGNOS presents an intriguing opportunity for investors, but a careful analysis of market conditions and company performance will be critical to making an informed decision.